 Immunomodulation
"Immunomodulation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances.
| Descriptor ID |
D056747
|
| MeSH Number(s) |
E02.095.465 G12.535
|
| Concept/Terms |
Immunomodulation- Immunomodulation
- Immunomodulations
- Immunomodulatory Therapy
- Immunomodulatory Therapies
- Therapies, Immunomodulatory
- Therapy, Immunomodulatory
|
Below are MeSH descriptors whose meaning is more general than "Immunomodulation".
Below are MeSH descriptors whose meaning is more specific than "Immunomodulation".
This graph shows the total number of publications written about "Immunomodulation" by people in this website by year, and whether "Immunomodulation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 3 | 4 | | 2011 | 0 | 3 | 3 | | 2012 | 0 | 4 | 4 | | 2013 | 2 | 0 | 2 | | 2014 | 2 | 3 | 5 | | 2015 | 2 | 1 | 3 | | 2016 | 3 | 2 | 5 | | 2017 | 3 | 4 | 7 | | 2018 | 4 | 4 | 8 | | 2019 | 2 | 6 | 8 | | 2020 | 4 | 2 | 6 | | 2021 | 4 | 2 | 6 | | 2022 | 0 | 3 | 3 | | 2023 | 0 | 2 | 2 | | 2024 | 1 | 1 | 2 | | 2025 | 1 | 1 | 2 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunomodulation" by people in Profiles.
-
Campa-Carranza JN, Capuani S, Willman MA, Rabassa A, Joubert AL, Bo T, Franco L, Conte M, Anaya-García AL, Rome GE, Ouni R, Seaborne HJ, Caffey CA, Berman DM, Zheng J, Paez-Mayorga J, Chua CYX, Chen SH, Kenyon NS, Grattoni A. Profiling Localized Immunomodulation and Drug Biodistribution within a Subcutaneous Vascularized Niche for Cell Transplantation. Adv Sci (Weinh). 2026 May; 13(28):e20914.
-
D'Alessandro A, Zimring JC. From metabolomics to transfusion-associated immunomodulation. Curr Opin Immunol. 2025 Oct; 96:102646.
-
Teles LN, Beatty LA, Hernandez AV, Mendoza MA, Wilkes ZM, Dominick VP, Argy Telias MT, Miller B, Huang CY, Bechi Genzano C, Andreopoulos FM, Dauer EA, Creusot RJ, Tomei AA. Engineered macroporous gelatin scaffolds enhance lymph node fibroblastic reticular cell identity and enable diabetogenic T cell immunomodulation. Biomaterials. 2026 Jan; 324:123460.
-
Kwak-Kim J, Maier CC, Villano CM, Bowman CJ, Brennan FR, Stanislaus D, Hillegas A, Krayer J, Prell RA, Papenfuss TL, Cauvin A, Gamse J, Dahlman A, Enright B, Leshin L, Rao GK, Helms W, Fuller CL, Yang X, Chen C, Mitchell-Ryan S. Assessing the impact and risk of immunomodulatory compounds on pregnancy. J Reprod Immunol. 2025 Jun; 169:104453.
-
Morandini L, Heath T, Sheakley LS, Avery D, Grabiec M, Friedman M, Martin RK, Boyd J, Olivares-Navarrete R. Adoptive transfer of immunomodulatory macrophages reduces the pro-inflammatory microenvironment and increases bone formation on titanium implants. Acta Biomater. 2024 10 15; 188:432-445.
-
Capuani S, Campa-Carranza JN, Hernandez N, Chua CYX, Grattoni A. Modeling of a Bioengineered Immunomodulating Microenvironment for Cell Therapy. Adv Healthc Mater. 2025 02; 14(5):e2304003.
-
Koduri G, Solomon JJ. Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2023 12; 75(12):2067-2077.
-
Faraoni EY, O'Brien BJ, Strickland LN, Osborn BK, Mota V, Chaney J, Atkins CL, Cen P, Rowe J, Cardenas J, Poulsen KL, Wray CJ, Thosani NC, Bailey-Lundberg JM. Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer. Cancer Immunol Res. 2023 01 03; 11(1):4-12.
-
Wang WL, Kasamatsu J, Joshita S, Gilfillan S, Di Luccia B, Panda SK, Kim DH, Desai P, Bando JK, Huang SC, Yomogida K, Hoshino H, Fukushima M, Jacobsen EA, Van Dyken SJ, Ruedl C, Cella M, Colonna M. The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4+ eosinophils unique to the small intestine. Proc Natl Acad Sci U S A. 2022 06 07; 119(23):e2204557119.
-
Viswanath DI, Liu HC, Capuani S, Vander Pol RS, Saunders SZ, Chua CYX, Grattoni A. Engineered implantable vaccine platform for continuous antigen-specific immunomodulation. Biomaterials. 2022 02; 281:121374.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|